市場調查報告書
商品編碼
1184273
血管閉合裝置全球市場規模,份額和行業趨勢分析報告:按應用(腹腔鏡手術,普外科),最終用途,產品(儀器,發電機,配件),區域展望和預測2022-2028Global Vessel Sealing Devices Market Size, Share & Industry Trends Analysis Report By Application (Laparoscopic Surgery and General Surgery), By End Use, By Product (Instruments, Generators and Accessories), By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,血管閉合裝置的全球市場規模預計將達到 26 億美元,在預測期內以 9.7% 的複合年增長率增長。
傳統的單極裝置具有較大的橫向熱擴散和不精確且微弱的血管閉合。 現代外科實踐中最常用的兩種止血能量裝置是雙極和超聲波。
現代雙極設備阻止電流通過設備的爪傳播,密封血管,並使用電熱能最大限度地減少對周圍組織的損害。 另一方面,超聲波設備使用高頻振動而不是電流,但能量在設備的鉗口之間傳輸得非常薄。
COVID-19 影響分析
在這種情況下,醫療機構實行行動限制,學術團體和監管部門發出推遲擇期手術的建議,絕大部分國家被封鎖。 結果,對容器密封裝置的需求減少了。 隨著COVID-19疫情進入恢復期,腹腔鏡手術有望恢復正常。 此外,COVID-19 大流行推動了腹腔鏡器械的一次性使用。 由於腹腔鏡手術是一次性的,因此不易發生交叉污染,具有在大流行期間可以使用的優勢。 因此,自大流行以來,血管閉合裝置市場迅速復蘇。
市場增長因素
新技術驅動全球市場
對微創血管閉合裝置的需求是由婦科、泌尿科、心髒病學、骨科和普通外科領域不斷增長的需求推動的。 新的軟件和復雜的血管閉合裝置的開發實現了連續的血管閉合工作流程,使外科醫生能夠高效地執行快速、準確和無痛的手術。
對微創手術的興趣與日俱增
與傳統的開放手術相比,微創手術的特點是恐懼感小。 傳統的腹腔鏡手術既困難又痛苦。 該手術使用小型專用儀器和通過小切口插入的微創腹腔鏡照相機。 微創手術後,患者可以恢復得更快,痛苦也更少。 隨著微創手術的普及,血管封閉裝置的市場可能會擴大。
市場障礙
血管閉合裝置的問題
雖然血管內密封裝置有許多優點,但一些缺點可能會阻礙行業的發展。 由於側向熱能分佈,血管密封方法可能會損傷神經、輸尿管和腸道。 這種橫向能量分散會損壞 2 毫米的組織。 在 2020 年的一篇文章中,Shozaburo Oyama 說 LigaSure 可能導致手術困難。 LigaSure 無法擠壓重要的血管和神經,因為厚而緻密的組織無法容納在刀片之間。 還有血管密封裝置的問題,預計會阻礙業務發展。
應用展望
血管固定器械市場按應用細分為腹腔鏡手術和普外科。 到 2021 年,普外科將在血管閉合器市場中佔據很大的收入份額。 這是由於其在乙狀結腸切除術和盲腸切除術等手術中的頻繁選擇。 這種偏好可以解釋為這些手術比腹腔鏡手術的成功率更高。 普外科手術價格高、術後住院時間長,市場佔有率小。
產品展望
血管閉合裝置市場按產品細分為發生器、儀器和配件。 2021 年,發電機細分市場在容器密封行業中佔據了重要的收入份額。 雙極和血管封閉治療由電外科發電機提供動力,也稱為血管封閉發電機。 能量裝置越來越多地用於血管封閉和消融的微創手術。 這些發生器在預定的時間段內向血管輸送精確的能量和電極壓力,以實現血管腔的完全和長期融合。
結束使用 Outlook
血管閉合裝置市場根據最終用戶細分為門診手術中心、醫院和專科診所。 2021 年血管閉合器械市場將在醫院領域佔據最大的收入份額。 這是在醫院進行更多手術的結果。 特別是可重複使用的容器密封系統可為最終用戶提供高效率和成本節約。 與一次性裝置相比,在全頸翻修手術中使用的可重複使用的血管閉合裝置可以顯著降低醫療成本。
區域展望
按地區劃分,血管閉合裝置市場分為北美、歐洲、亞太地區和 LAMEA。 2021年,北美地區主導了血管閉合器市場。 在美國和加拿大,擁有最先進技術的重要公司和醫院佔據了該地區的重要市場份額。 此外,由於不良的飲食習慣、對即食零食的渴望、缺乏運動、壓力大的生活方式以及相當大的人口老齡化,美國慢性疾病的患病率正在上升。這促進了市場擴張。
The Global Vessel Sealing Devices Market size is expected to reach $2.6 billion by 2028, rising at a market growth of 9.7% CAGR during the forecast period.
By totally occluding the blood vessel and denaturing the collagen and elastin in the vessel wall, vessel sealing devices are utilized to seal the vessel wall. The most popular energy-based surgical instruments include hybrid, ultrasonic, and bipolar.
In both open and laparoscopic operations, energy-based vascular sealing devices (VSDs) have been created to speed up dissection and hemostasis. With less blood loss and shorter operating periods, these technologies allow surgeons to increase the effectiveness and safety of surgeries. In modern medicine, there is a constant demand for technological advancement to manufacture high-quality VSDs with more accurate vascular sealing quality and less heat harm to surrounding tissues.
Traditional monopolar devices have increased lateral heat spread and uncertain, weak vessel sealing. The two types of hemostatic energy devices that are most frequently employed in modern surgical practice are bipolar and ultrasonic ones.
Modern bipolar devices stop electric current from spreading through the device's jaws, sealing blood vessels and minimizing damage to the tissues around them with electrothermal energy. In contrast, ultrasonic devices use high-frequency vibrations rather than electrical current, but the energy can only be transmitted very thinly between the device's jaws.
COVID-19 Impact Analysis
Movement restrictions were implemented, and the majority of countries went into lockdown as academic societies and regulatory authorities advised delaying elective surgical procedures. All of this led to a decline in the demand for vessel sealing devices. It is anticipated that laparoscopic device procedures would return to normal as the COVID-19 pandemic's recovery phase gets underway. Additionally, the COVID-19 pandemic promoted the use of disposable laparoscopic instruments. Cross-contamination is prevented by single-use laparoscopic instruments, which proved to be an advantageous circumstance for their use throughout the COVID-19 pandemic. As a result, the market for vessel sealing devices has quickly recovered since the pandemic.
Market Growth Factors
New Technologies To Drive The Global Market
The demand for minimally invasive vessel sealing devices has been driven by the rise in gynecological, urological, cardiology, orthopedic, and general surgery needs. A continuous vessel-sealing device workflow is delivered through the development of new software and sophisticated vessel-sealing devices, allowing the surgeon to do quick, accurate, painless surgeries with increased efficiency.
Rising Interest In Minimally Invasive Procedures
Compared to traditional open surgeries, minimally invasive surgeries are significantly less frightening. Traditional procedures carried out using standard laparoscopic tools can be difficult and distressing. The procedure is carried out with the assistance of specialized, smaller equipment and minimally invasive laparoscopic cameras that are placed through smaller incisions. After minimally invasive operations, patients can recover more quickly and with less pain. The market for vessel sealing devices may expand as minimally invasive operations become more popular.
Market Restraining Factors
Problems With Using Vessel Sealing Devices
Despite the many advantages of vessel sealing systems, some disadvantages can prevent the industry from expanding. Vessel sealing methods can damage nerves, ureters, and bowels as a result of lateral thermal energy distribution. 2 mm of tissue is damaged by this lateral energy dispersion. In a 2020 essay, Shosaburo Oyama said that LigaSure could lead to surgical difficulties. Due to the inability of thick, dense tissues to fit between blades, LigaSure is unable to clamp vital blood vessels and nerves. It is anticipated that issues with vessel sealing devices may hinder the business.
Application Outlook
On the basis of Application, the Vessel Sealing Devices Market is divided into Laparoscopic Surgery and General Surgery. In the market for vessel sealing devices in 2021, the general surgery sector accounted for a sizeable revenue share. This is due to the fact that it is frequently chosen in procedures like sigmoidectomies and appendectomies. This preference may be explained by the superior success rate of these procedures over laparoscopy. General procedures have a small market share due to their high price and extended post-operative hospital stay.
Product Outlook
Based on the product, the vessel sealing devices market is divided classified into generators, instruments, and accessories. In 2021, the generators market segment showcased the significant revenue share in the vessel sealing industry. Bipolar and vessel sealing treatments are powered by electrosurgical generators, also referred to as vessel sealing generators. Energy devices are increasingly used in minimally invasive surgery for vessel sealing and dissection. These generators give accurate energy and electrode pressure to vessels for a predefined period of time in order to accomplish a full and long-lasting fusion of the vessel lumen.
End-use Outlook
Based on End-use, the market for vessel sealing devices is segmented into ambulatory surgery centers, hospitals, and specialized clinics. The market for vessel sealing devices in 2021 saw the biggest revenue share in the hospital sector. This is a result of more procedures being carried out in hospital settings. Reusable vessel sealing systems, in particular, provide end users with greater effectiveness and cost savings. Compared to disposable devices, reusable vascular sealing devices used during modified total neck dissection operations can dramatically lower medical expenses.
Regional Outlook
By geography, the vessel sealing devices market is categorized into North America, Europe, Asia Pacific, and LAMEA. In 2021, the North American region dominated the vessel sealing devices market. The presence of significant firms and hospitals with cutting-edge technology in the United States and Canada accounts for the region's considerable market share. Additionally, the rising prevalence of chronic medical disorders in the US as a result of bad eating habits, a desire for quick-to-prepare snacks, a lack of exercise, a stressful lifestyle, and a sizable older population is encouraging market expansion.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, B. Braun Melsungen AG, Johnson & Johnson, Intuitive Surgical, Inc., Hologic, Inc. (Bolder Surgical), Erbe Elektromedizin GmbH, BOWA-electronic GmbH & Co. KG, OmniGuide, Inc., and KLS Martin Group.
Strategies deployed in Vessel Sealing Devices Market
Sep-2022: Olympus Corporation introduced THUNDERBEAT Open Fine Jaw Type X surgical energy devices to support safer procedures for open surgery. The product is designed to deliver ultrasonic and bipolar energy concurrently that allow genuine vessel division and sealing, speedy hemostatic cutting and easy dissection.
Jan-2022: Erbe Elektromedizin launched Biclamp Knife 220, a product designed to seal and cut vessels during surgical procedures and simplify the surgery. The product built with the capability to anatomize close to critical structures, seal vessels up to 7mm in diameter, manage diffuse bleedings of larger surface areas as well as stop inadvertent thermal effects to adjoining tissue as the temperature on the back of the jaws would be about below 40°C.
Nov-2021: Hologic, Inc. acquired Bolder Surgical to add dissecting devices, vessel sealing, and dividing to its surgical portfolio. With this acquisition, all the Bolder's devices would be added to the Hologic product offering including JustRight 3mm vessel sealer, JustRight 5mm stapler, and CoolSeal vessel sealing suite. Additionally, this would enhance the company's OB/GYN specialists.
Sep-2021: Olympus announced the launch of POWERSEAL, an Advanced Bipolar Surgical Energy single-use Devices. This launch strengthens the Surgical suite, the device is built with the feature of efficient and strong sealing of vessels, Minimal thermal spread with low exterior jaw temperature and Fast cool-down times, Multifunctional capabilities as well as dependability of 3x systolic blood pressure.
Jan-2021: Bolder Surgical introduced the CoolSeal Vessel Sealing platform, with an aim to enlarge the offering of vessel sealing products. The platform launch contains the CoolSeal generator, a 3mm CoolSeal Mini vessel sealer, and the CoolSeal Trinity, a new 5 mm laparoscopic vessel sealer surgical instrument used for urological, gynecological, and general surgery. CoolSeal Trinity contains 360-degree capability with dual-action jaws that allows quick sealing time and precise dissection along with the least thermal distribution surrounding major structures.
Jul-2020: BOWA Medical announced an agreement with Lexington Medical, a supplier of minimally-invasive surgical stapling solutions. Under the agreement, the LOTUS system, made by BOWA Medical, and AEON Endostapler, made by Lexington Medical would be marketed jointly by both companies globally. This would strengthen their best-in-class manufacturing and product leadership globally.
Dec-2019: Intuitive received FDA approval for SynchroSeal and E-100 generator that would be used in sealing procedures. SynchroSeal was a robotic system sealing instrument used to transect tissue whereas the E-100 generator provides power to SynchroSeal. The products were designed to empower surgeons to carry out transaction with a single pedal press and quick one-step sealing.
Apr-2018: Medtronic PLC launched LigaSure exact dissector, which offers two times faster cooling with precise dissection and superior access. The newly launch product is based on LigaSure™ vessel sealing technology, which makes it easy to seal and cut as well as, with its fine, curved jaw maximizes the line of sight.
Market Segments covered in the Report:
By Application
By End Use
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures